GlassScriptPhysician profile
Nicholas Stephen Andrade
NPI 1497919310
$8,076.79
in general payments reported to CMS, 2019-2025
30 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $3,987 · 2021: $1,873 · 2022: $91.38 · 2023: $1,037 · 2024: $221 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283 · Travel and Lodging: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.95 |
| Travel and Lodging | $457.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,693.56 | 2020-2021 | |
| Globus Medical, INC. | $722.60 | 2021-2023 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Relievant Medsystems, INC. | $362.70 | 2020-2021 | |
| Medtronic, INC. | $348.49 | 2021-2025 | Inceptiv, O-Arm |
| Omniscient Neurotechnology America LTD | $248.12 | 2023 | Quicktome |
| Cerapedics INC. | $154.54 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Innovation Technologies INC | $147.12 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $136.75 | 2019-2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Surgalign Spine Technologies, INC. | $127.19 | 2021 | |
| Acacia Pharma INC | $120.82 | 2021 | |
| Boston Scientific Corporation | $118.68 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $102.49 | 2023 | Infinity |
| Kuros Biosciences USA, INC | $100.00 | 2025 | Magnetos |
| Heron Therapeutics, INC. | $92.45 | 2025 | Zynrelef |
| Camber Spine Technologies LLC | $83.89 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $81.38 | 2019 | |
| Stryker Corporation | $73.61 | 2024 | Spinejack, Omnicurve |
| Novocure INC. | $60.44 | 2020 | |
| Spinal Simplicity, LLC | $50.55 | 2021 | |
| Depuy Synthes Sales INC. | $30.60 | 2023 | Teligen, Conduit |
| Argenx US, INC. | $30.58 | 2025 | Vyvgart Hytrulo |
| Acorda Therapeutics, INC | $29.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.34 | 2019 | |
| Ethicon US, LLC | $23.62 | 2022 | |
| Biogen, INC. | $22.50 | 2019 | |
| Olympus America INC. | $19.60 | 2022 | |
| Neurocrine Biosciences, INC. | $19.57 | 2019 | |
| Natus Medical Incorporated | $18.49 | 2019 | |
| Radius Health, INC. | $17.72 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.